Analgesic onset and efficacy of a fast-acting formulation of acetaminophen in a postoperative dental impaction pain model.

The relationship of within-individual and between-individual variation in mental health with bodyweight: An exploratory longitudinal study.

ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits.

Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.

Patient-reported outcomes and pharmacist actions in patients with multiple sclerosis managed by health-system specialty pharmacies.

Optimizing HIV PrEP Persistence: Does Your Pharmacy Matter?

Therapy outcomes associated with prescription cannabidiol use at 12Â months post-initiation.

Low-intensity open-field blast exposure effects on neurovascular unit ultrastructure in mice.

Case 26-2023: A 15-Year-Old Girl with Abdominal Pain and an Ovarian Mass.

Iron Regulatory Protein 1 is Required for the Propagation of Inflammation in Inflammatory Bowel Disease.

First Dark Matter Search Results from the LUX-ZEPLIN (LZ) Experiment.

Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.

Patient-Tailored Interventions to Improve Specialty Medication Adherence: Results from a Prospective Randomized Controlled Trial.

Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.

Health Insurer Strategies to Reduce Specialty Drug Spending-Copayment Adjustment and Alternative Funding Programs.